Argenx Se (ARGX) Finished Goods (2021 - 2024)
Argenx Se's (ARGX) quarterly Finished Goods came in at $38.4 million in Q2 2024, up 31.64% YoY from $29.2 million in Q3 2023, and up 69.66% on a QoQ basis from $22.6 million in Q4 2023.
Argenx Se (ARGX) Finished Goods (2021 - 2024) Analysis & Trends
Argenx Se (ARGX) has 4 years of Finished Goods data on file, last reported at $38.4 million in Q2 2024.
- Quarterly Finished Goods rose 31.64% year-over-year to $38.4 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $38.4 million (up 31.64% YoY) and the FY2023 annual result came in at $22.6 million, down 39.29% from the prior year.
- Finished Goods grew to $38.4 million in Q2 2024, from $22.6 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $38.4 million in Q2 2024 to a low of $1.2 million in Q4 2021.
- A 4-year average of $24.9 million and a median of $25.9 million in 2023 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2022 — Finished Goods jumped 2914.63% — and 2023, when it sank 39.29%.
- Tracing ARGX's Finished Goods over 4 years: stood at $1.2 million in 2021, then jumped by 2914.63% to $37.3 million in 2022, then slumped by 39.29% to $22.6 million in 2023, then jumped by 69.66% to $38.4 million in 2024.
- The last three Finished Goods figures came in at $38.4 million (Q2 2024), $22.6 million (Q4 2023), and $29.2 million (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 38.41 Mn |
| Dec 31, 2023 | 22.64 Mn |
| Jun 30, 2023 | 29.18 Mn |
| Dec 31, 2022 | 37.29 Mn |
| Jun 30, 2022 | 20.91 Mn |
| Dec 31, 2021 | 1.24 Mn |